Biomarin Pharmaceutical (BMRN) Non-Current Deffered Revenue (2010 - 2012)
Biomarin Pharmaceutical (BMRN) posted Non-Current Deffered Revenue of $13.1 million for Q3 2012, up 6.47% on a QoQ basis from $12.3 million in Q2 2012, and up 1222.66% year-over-year from $993000.0 in Q4 2011.
Biomarin Pharmaceutical (BMRN) Non-Current Deffered Revenue (2010 - 2012) Analysis & Trends
Biomarin Pharmaceutical's Non-Current Deffered Revenue history runs 3 years deep, the most recent figure standing at $13.1 million for Q3 2012.
- Quarterly Non-Current Deffered Revenue rose 1222.66% year-over-year to $13.1 million in Q3 2012, while the trailing twelve-month figure through Sep 2012 was $13.1 million (up 1222.66% YoY) and the FY2011 annual result came in at $950000.0, down 81.78% from the prior year.
- Non-Current Deffered Revenue was $13.1 million for Q3 2012 at Biomarin Pharmaceutical, up from $12.3 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $13.1 million in Q3 2012 and bottomed at $950000.0 in Q4 2011.
- A 3-year average of $6.1 million and a median of $5.2 million in 2010 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2011 — Non-Current Deffered Revenue slumped 81.78% — and 2012, when it soared 1222.66%.
- Biomarin Pharmaceutical's Non-Current Deffered Revenue stood at $5.2 million in 2010, then slumped by 81.78% to $950000.0 in 2011, then jumped by 1282.53% to $13.1 million in 2012.
- Business Quant data shows BMRN's Non-Current Deffered Revenue at $13.1 million in Q3 2012, $12.3 million in Q2 2012, and $8.8 million in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 13.13 Mn |
| Jun 30, 2012 | 12.34 Mn |
| Mar 31, 2012 | 8.77 Mn |
| Dec 31, 2011 | 950,000.00 |
| Sep 30, 2011 | 993,000.00 |
| Jun 30, 2011 | 991,000.00 |
| Dec 31, 2010 | 5.21 Mn |